Group A and C meningococcal polysaccharide vaccines

After vaccination, this vaccine can produce humoral immune response. It is used to prevent epidemic cerebrospinal meningitis caused by group A and group C meningococci. Children over 2 years old and adults, and children under 3 years old in epidemic areas can receive emergency vaccination.

1. It is contraindicated for patients with epilepsy, convulsions, brain diseases and a history of allergies; 2. It is contraindicated for patients with kidney disease, heart disease and active tuberculosis; 3. It is contraindicated for patients with acute infectious diseases and fever.

After reconstitution, each bottle contains 0.5 ml. Each human dose is 0.5 ml, containing 50 ug each of group A and group C meningococcal capsular polysaccharides.